{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T13:00:04Z","timestamp":1767963604034,"version":"3.49.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1097\/mca.0000000000000518","type":"journal-article","created":{"date-parts":[[2017,7,7]],"date-time":"2017-07-07T14:19:02Z","timestamp":1499437142000},"page":"533-538","source":"Crossref","is-referenced-by-count":6,"title":["Bioresorbable vascular scaffolds"],"prefix":"10.1097","volume":"28","author":[{"given":"Hiroyoshi","family":"Mori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renu","family":"Virmani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aloke V.","family":"Finn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-1-20210204","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0140-6736(08)60415-8","article-title":"A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial","volume":"371","author":"Ormiston","year":"2008","journal-title":"Lancet"},{"key":"R2-1-20210204","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0140-6736(15)00979-4","article-title":"Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials","volume":"387","author":"Cassese","year":"2016","journal-title":"Lancet"},{"key":"R3-1-20210204","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1016\/S0140-6736(16)32050-5","article-title":"Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial","volume":"388","author":"Serruys","year":"2016","journal-title":"Lancet"},{"key":"R5-1-20210204","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jcin.2016.10.027","article-title":"Very late scaffold thrombosis of bioresorbable vascular scaffold: systematic review and a meta-analysis","volume":"10","author":"Toyota","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"R8-1-20210204","doi-asserted-by":"crossref","first-page":"60","DOI":"10.4244\/EIJY15M02_03","article-title":"An independent bench comparison of two bioresorbable drug-eluting coronary scaffolds (Absorb and DESolve) with a durable metallic drug-eluting stent (ML8\/Xpedition)","volume":"11","author":"Ormiston","year":"2015","journal-title":"EuroIntervention"},{"key":"R9-1-20210204","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.jacc.2015.12.019","article-title":"Bioresorbable coronary scaffold thrombosis: multicenter comprehensive analysis of clinical presentation, mechanisms, and predictors","volume":"67","author":"Puricel","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"R10-1-20210204","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1093\/eurheartj\/ehv711","article-title":"Mechanisms of stent thrombosis analysed by optical coherence tomography: insights from the national PESTO French registry","volume":"37","author":"Souteyrand","year":"2016","journal-title":"Eur Heart J"},{"key":"R11-1-20210204","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1093\/eurheartj\/ehv205","article-title":"Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment","volume":"36","author":"Otsuka","year":"2015","journal-title":"Eur Heart J"},{"key":"R12-1-20210204","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.4244\/EIJ-D-16-00471","article-title":"Possible mechanical causes of scaffold thrombosis: insights from case reports with intracoronary imaging","volume":"12","author":"Sotomi","year":"2017","journal-title":"EuroIntervention"},{"key":"R13-1-20210204","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.4244\/EIJY15M10_03","article-title":"Comparative analysis method of permanent metallic stents (XIENCE) and bioresorbable poly-L-lactic (PLLA) scaffolds (Absorb) on optical coherence tomography at baseline and follow-up","volume":"12","author":"Nakatani","year":"2016","journal-title":"EuroIntervention"},{"key":"R14-1-20210204","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/ehjci\/jew070","article-title":"Optical coherence tomography evaluation of intermediate-term healing of different stent types: systemic review and meta-analysis","volume":"18","author":"Iannaccone","year":"2017","journal-title":"Eur Hear J Cardiovasc Imaging"},{"key":"R15-1-20210204","doi-asserted-by":"crossref","first-page":"20131079","DOI":"10.1098\/rsif.2013.1079","article-title":"Macro- and microscale variables regulate stent haemodynamics, fibrin deposition and thrombomodulin expression","volume":"11","author":"Jim\u00e9nez","year":"2014","journal-title":"J R Soc Interface"},{"key":"R16-1-20210204","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.jcin.2014.06.016","article-title":"Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb everolimus-eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (a clinical evaluation of the bioabsorbable everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions)","volume":"7","author":"Onuma","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"R17-1-20210204","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1093\/eurheartj\/ehv581","article-title":"Coronary evaginations and peri-scaffold aneurysms following implantation of bioresorbable scaffolds: incidence, outcome, and optical coherence tomography analysis of possible mechanisms","volume":"37","author":"Gori","year":"2015","journal-title":"Eur Heart J"},{"key":"R18-1-20210204","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jjcc.2016.06.013","article-title":"Relationship between peri-strut low intensity areas and vascular healing response after everolimus-eluting bioresorbable scaffold implantation: an optical coherence tomography study","volume":"69","author":"Sato","year":"2017","journal-title":"J Cardiol"},{"key":"R19-1-20210204","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1016\/j.jcin.2016.09.016","article-title":"Histopathological differential diagnosis of optical coherence tomographic image interpretation after stenting","volume":"9","author":"Lutter","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"R20-1-20210204","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/MCA.0000000000000134","article-title":"Peri-strut low-intensity areas in optical coherence tomography correlate with peri-strut inflammation and neointimal proliferation","volume":"25","author":"Tellez","year":"2014","journal-title":"Coron Artery Dis"},{"key":"R21-1-20210204","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1161\/CIRCINTERVENTIONS.112.968487","article-title":"Optical coherence tomography findings in lesions after sirolimus-eluting stent implantation with peri-stent contrast staining","volume":"5","author":"Tada","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"R22-1-20210204","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1093\/eurheartj\/eht344","article-title":"Coronary evaginations are associated with positive vessel remodelling and are nearly absent following implantation of newer-generation drug-eluting stents: an optical coherence tomography and intravascular ultrasound study","volume":"35","author":"Radu","year":"2014","journal-title":"Eur Heart J"},{"key":"R23-1-20210204","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/ccd.26913","article-title":"Intraluminal bioresorbable vascular scaffold dismantling with aneurysm formation leading to very late thrombosis","volume":"89","author":"Patel","year":"2017","journal-title":"Catheter Cardiovasc Interv"},{"key":"R24-1-20210204","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1161\/CIRCINTERVENTIONS.113.000990","article-title":"Long-term safety of an everolimus-eluting bioresorbable vascular scaffold and the cobalt-chromium XIENCE V stent in a porcine coronary artery model","volume":"7","author":"Otsuka","year":"2014","journal-title":"Circ Cardiovasc Interv"},{"key":"R25-1-20210204","doi-asserted-by":"crossref","first-page":"e002427","DOI":"10.1161\/CIRCINTERVENTIONS.115.002427","article-title":"Thrombogenicity and early vascular healing response in metallic biodegradable polymer-based and fully bioabsorbable drug-eluting stents","volume":"8","author":"Koppara","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"R26-1-20210204","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/eurheartj\/ehv500","article-title":"Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction-TROFI II trial","volume":"37","author":"Sabat\u00e9","year":"2016","journal-title":"Eur Heart J"},{"key":"R27-1-20210204","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.jcin.2015.03.031","article-title":"Recurrent neoatherosclerosis after bioresorbable vascular scaffold treatment of in-stent restenosis","volume":"8","author":"Bastante","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"R28-1-20210204","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10554-016-0967-0","article-title":"Bioresorbable vascular scaffold fracture in the overlapping zone as cause of accelerated neoatherosclerosis and in-scaffold very-late thrombosis","volume":"33","author":"Mangiameli","year":"2017","journal-title":"Int J Cardiovasc Imaging"},{"key":"R29-1-20210204","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jacc.2008.01.076","article-title":"Provoked coronary spasm predicts adverse outcome in patients with acute myocardial infarction","volume":"52","author":"Wakabayashi","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R30-1-20210204","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.jacc.2011.05.050","article-title":"Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes","volume":"58","author":"Serruys","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R31-1-20210204","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.phrs.2016.08.003","article-title":"The paracrine control of vascular motion. A historical perspective","volume":"113","author":"Nava","year":"2016","journal-title":"Pharmacol Res"}],"container-title":["Coronary Artery Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000000518","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:41:54Z","timestamp":1620960114000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00019501-201711000-00001"}},"subtitle":["implication of very late scaffold thrombosis"],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/mca.0000000000000518","relation":{},"ISSN":["0954-6928"],"issn-type":[{"value":"0954-6928","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]}}}